Jong M. Rho
Affiliations: | Barrow Neurological Institute, Phoenix, AZ, United States |
Area:
epilepsy, neuropharmacology, ketogenic dietWebsite:
http://www.thebarrow.org/About_Barrow/Bios/Group_3/Rho_Jong_MD/index.htmGoogle:
"Jong Rho"Mean distance: 13.63 (cluster 6) | S | N | B | C | P |
Children
Sign in to add trainee| Marwan Maalouf | post-doc | Barrow Neurological Institute | |
| Kristina A. Simeone | post-doc | Barrow Neurological Institute | |
| Timothy A. Simeone | post-doc | 2005-2008 | Barrow Neurological Institute |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| George AG, Farrell JS, Colangeli R, et al. (2023) Sudden unexpected death in epilepsy is prevented by blocking postictal hypoxia. Neuropharmacology. 231: 109513 |
| Rho JM, Boison D. (2022) The metabolic basis of epilepsy. Nature Reviews. Neurology |
| Choudhary A, Mu C, Barrett KT, et al. (2021) The link between brain acidosis, breathing and seizures: a novel mechanism of action for the ketogenic diet in a model of infantile spasms. Brain Communications. 3: fcab189 |
| Johannesen KM, Liu Y, Koko M, et al. (2021) Genotype-phenotype correlations in SCN8A-related disorders reveal prognostic and therapeutic implications. Brain : a Journal of Neurology |
| Cervenka M, Pascual JM, Rho J, et al. (2021) Metabolism-based therapies for epilepsy: new directions for future cures. Annals of Clinical and Translational Neurology |
| Simeone KA, Wilke JC, Matthews SA, et al. (2021) Ketogenic diet-mediated seizure reduction preserves CA1 cell numbers in epileptic Kcna1-null mice: An unbiased stereological assessment. Epilepsia |
| Gavrilovici C, Rho JM. (2020) Metabolic Epilepsies Amenable to Ketogenic Therapies: Indications, Contra-indications and Underlying Mechanisms. Journal of Inherited Metabolic Disease |
| Kiroski I, Jiang Y, Gavrilovici C, et al. (2020) Reelin Improves Cognition and Extends the Lifespan of Mutant Ndel1 Mice with Postnatal CA1 Hippocampus Deterioration. Cerebral Cortex (New York, N.Y. : 1991) |
| Ibhazehiebo K, Rho JM, Kurrasch DM. (2020) Metabolism-based drug discovery in zebrafish: An emerging strategy to uncover new anti-seizure therapies. Neuropharmacology. 167: 107988 |
| Poff AM, Rho JM, D'Agostino DP. (2019) Ketone Administration for Seizure Disorders: History and Rationale for Ketone Esters and Metabolic Alternatives. Frontiers in Neuroscience. 13: 1041 |